Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors
I'm PortAI, I can summarize articles.
Corbus Pharmaceuticals Holdings Inc. (CRBP) shares fell 2.86% to $11.54 on Friday, underperforming compared to competitors like Vanda Pharmaceuticals, Fortress Biotech, and Viking Therapeutics, which saw gains. The stock is 43.87% below its 52-week high of $20.56. Trading volume was significantly below the 50-day average. This occurred during a favorable trading session for the broader market, with the NASDAQ and Dow Jones indices both rising.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments